← All indications
Hepatitis D, Chronic
INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS in conjunction with HEPATITIS B VIRUS and lasting six months or more.
Drugs by status
Phase 4 trials (2)
Phase 3 trials (4)
Phase 2 trials (12)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (12)
- Gilead Sciences
- Eiger BioPharmaceuticals
- Hannover Clinical Trial Center GmbH
- German Liver Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Gottfried Wilhelm Leibniz Universität Hannover
- Aga Khan University
- University of Ankara
- Moscow Regional Resarch adn Clinical Institute
- Janssen Pharmaceutica NV
- Data Matrix, LTD
- Ziauddin University
Organization Involved with Phase 1 Indications (1)